<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/24B22393-0813-4A95-8DFA-3AB068F9438D"><gtr:id>24B22393-0813-4A95-8DFA-3AB068F9438D</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Gamblin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7C9FE3A2-64B4-4511-BA18-51002CB88BE8"><gtr:id>7C9FE3A2-64B4-4511-BA18-51002CB88BE8</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Skehel</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600522"><gtr:id>47000280-7D26-433A-B05A-82ED4ECAFB9F</gtr:id><gtr:title>Receptor binding studies of H5 haemagglutinins</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600522</gtr:grantReference><gtr:abstractText>Receptor binding is the first step in influenza virus infection. We will analyse this process for recent H5N1 viruses to provide information on virus variation, virus surveillance and the potential for trans-species infection.</gtr:abstractText><gtr:technicalSummary>Influenza haemagglutinin (HA) mediates the first step in virus infection sialic acid receptor
binding [1], is a principal factor in cell and species specificity [2], and, as the target of
infectivity neutralizing antibodies [3] is the major object of influenza surveillance [4]. We
have determined the structure of A/Duck/Singapore/3/97 Singapore (H5N1) HA [5]; [6] to
compare an avian HA of the H5 subtype with avian and human HAs of H1 and H3 subtypes,
and investigate in particular its receptor-binding properties. Because of the widespread
distribution of H5 viruses and their persistence in avian populations, we now intend to
examine the structures of HAs from three recent H5N1 viruses from humans. Our proposal is
in three inter-related parts.
1. We will determine by X-ray crystallography the structures of the HAs from two viruses
from Turkey that were recently isolated from clinical samples in the WHO Influenza Centre
at NIMR, and from one of the 2004 Vietnamese viruses that is in a different H5 antigenic
group. The structures will be determined as complexes with pentasaccharide analogues of
human and avian receptors.
2. The Turkish viruses differ from each other at two residues in the receptor binding site
SS227N and N158D. The substitution at 227 has been observed before in viruses from Hong
Kong and Vietnam and shown to influence haemagglutination of differently derivatized
erythrocytes, and receptor binding in an ELISA binding assay [7]; [8]; [9]. We also have
preliminary evidence that the Turkish mutant virus is resistant to oseltamivir and this is
consistent with the haemagglutination and ELISA experiments. To establish the basis of
these properties we will determine the specificities and affinities of the HAs using BIAcore
procedures that we have established and refined for HA-sialic acid interactions.
3. We intend to mutate the H5 HA binding site using a vaccinia-HA recombinant virus
system that we have used extensively [10], and to determine the effects of mutations on
receptor binding properties. Subsequently we will determine the structures of appropriate
mutant HAs.
By these experiments we will have determined the binding properties of H5 HAs, understand
their molecular basis, and established a receptor binding database for interpretation of the
results of future surveillance of H5 subtype viruses in relation to their potential for crossspecies
transfer and for an aspect of anti-neuraminidase drug resistance mediated by
mutant HAs.</gtr:technicalSummary><gtr:fund><gtr:end>2009-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>242600</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5D90EEDA-E165-4A8C-87F6-841844600230</gtr:id><gtr:title>A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f18113a2d750140919bbc345f2f67feb"><gtr:id>f18113a2d750140919bbc345f2f67feb</gtr:id><gtr:otherNames>Hu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>pm_14654_24_22238297</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0C29CF0-7EE8-49D5-94CA-6C074F85D5CD</gtr:id><gtr:title>Receptor binding by H10 influenza viruses.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b4c687eb15e5d35fe0acbde92cd5152"><gtr:id>0b4c687eb15e5d35fe0acbde92cd5152</gtr:id><gtr:otherNames>Vachieri SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5460d3c605a188.67897905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9CD417A4-61F7-4F12-B620-BACA3CBF1FA5</gtr:id><gtr:title>Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80a7be56e1751ece262fecbf341dbc5f"><gtr:id>80a7be56e1751ece262fecbf341dbc5f</gtr:id><gtr:otherNames>Yamada S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>78C0315AB33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B60B3BE-E09A-43AE-99DC-84DA0E999C70</gtr:id><gtr:title>Recent evolution of equine influenza and the origin of canine influenza.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5326701fa861c5afae566266fd3de076"><gtr:id>5326701fa861c5afae566266fd3de076</gtr:id><gtr:otherNames>Collins PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5460aba7e4e082.75512406</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA5C0977-F012-4FBE-8E08-9C3597508538</gtr:id><gtr:title>Structure and Function Analysis of an Antibody Recognizing All Influenza A Subtypes.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1721e137ddd00cac7c3a4dcbf0f81f6c"><gtr:id>1721e137ddd00cac7c3a4dcbf0f81f6c</gtr:id><gtr:otherNames>Kallewaard NL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58c979901c9881.65790930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA15A717-309D-4672-AA96-F01534DEF82B</gtr:id><gtr:title>Enhanced human receptor binding by H5 haemagglutinins.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>5460aba8159f13.02705442</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9038EE40-E8CE-463E-997B-07E3DBB7BBDA</gtr:id><gtr:title>Changes in the hemagglutinin of H5N1 viruses during human infection--influence on receptor binding.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f8a186f45719f9b90df8ad838fda1fd1"><gtr:id>f8a186f45719f9b90df8ad838fda1fd1</gtr:id><gtr:otherNames>Crusat M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>doi_14654_013_08_010</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49A096A3-1265-4356-A252-2B4C13789384</gtr:id><gtr:title>Structural basis of AMPK regulation by small molecule activators.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ea167df39b3dea34dd3da5e073e849d"><gtr:id>6ea167df39b3dea34dd3da5e073e849d</gtr:id><gtr:otherNames>Xiao B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5460aba85bb011.90505625</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>33935EF4-A515-465B-BE93-265021A08548</gtr:id><gtr:title>Recognition of sulphated and fucosylated receptor sialosides by A/Vietnam/1194/2004 (H5N1) influenza virus.</gtr:title><gtr:parentPublicationTitle>Virus research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0168-1702</gtr:issn><gtr:outcomeId>doi_14654_013_08_007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5017618D-7732-414A-B1C1-C896748B0790</gtr:id><gtr:title>Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibody.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c5b7df65b73711afafabedbac73ca4cb"><gtr:id>c5b7df65b73711afafabedbac73ca4cb</gtr:id><gtr:otherNames>Xiong X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5643221ccf6b72.14376940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2BD6954-D9E5-4B10-8B72-AF8C8DA627EE</gtr:id><gtr:title>Avian and human receptor binding by hemagglutinins of influenza A viruses.</gtr:title><gtr:parentPublicationTitle>Glycoconjugate journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3429df0f1fb4f1013e2e6f82c8183d45"><gtr:id>3429df0f1fb4f1013e2e6f82c8183d45</gtr:id><gtr:otherNames>Russell RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0282-0080</gtr:issn><gtr:outcomeId>563A70AA1C2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7EE2C38-91EF-435A-95CF-1F286E5EBC0A</gtr:id><gtr:title>Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3429df0f1fb4f1013e2e6f82c8183d45"><gtr:id>3429df0f1fb4f1013e2e6f82c8183d45</gtr:id><gtr:otherNames>Russell RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>EB89ABB9142</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600522</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>